A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
1 report, 1 independent
Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Mont-Saint-Guibert
municipality in Wallonia, Belgium
Nothing else this week.
Related events
- Clinical research studies for new indications were reported by the FDA concerning a company identified as Cpt.
- A product was launched in the U.S. market following FDA involvement.
- The FDA requested additional clinical data from Unicycive Therapeutics.
- A clinical study led by Dr. Swee Lay Thein is underway at the National Institutes of Health and is subject to oversight by the Food and Drug Administration.
- Jazz Pharmaceuticals received FDA approval for a drug following positive clinical trial results.